You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: October 20, 2020

DrugPatentWatch Database Preview

Litigation Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2019-05-09 31 Opinion - Memorandum Opinion the "#796 patent"), 9,572,797 (the "#797 patent"), and 10,010,533 (the "#533…equivalents of four patents: U.S. Patent Nos. 9,265,831 (the "#831 patent"), 9,572,796 …glycol in embodiments of the patented invention. See, e.g., #796 patent at 1 :60-64, 4:34-47, 5:27-35…;#533 patent"). See generally D.I. 1. Pending before me is Slayback's motion for judgment on…manufacture and sell before the four asserted patents expire a bendamustine drug that is bioequivalent External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.